In a recent study published in the international journal Cell, scientists from Oxford University and other institutions identified a human antibody that could inhibit malaria parasites from entering blood cells. Related researchRead More…
1. Nat Biotechnol: Edible antibody molecules contribute to the treatment of gastrointestinal diseases Therapeutic antibodies are increasingly used clinically to treat a variety of diseases. However, oral gut-targeted antibodies remain a challenge becauseRead More…
In 2018, Loxo Oncology’s “unlimited cancer” targeted therapy Vitrakvi was approved by FDA, becoming the first targeted therapy for patients with NTRK gene fusion variant solid tumors. Loxo, on the other hand,Read More…
In a new study, Researchers from institutions such as the University of Washington studied human monoclonal antibodies isolated from survivors of severe acute respiratory syndrome (SARS) or Middle East respiratory syndrome (MERS)Read More…
As life lies in movement, immunity relies on balance. A healthy individual has immune cells that can easily eradicate the recurring diseased cells in the body, including those potentially evolving to cancerousRead More…
In the past decade, tumor immunotherapy has overturned the traditional concept of treatment, especially the discovery and application of immune checkpoint molecules. The immune checkpoint can be irritating or inhibitory, and theRead More…